Home » Stocks » AMTI

Applied Molecular Transport, Inc. (AMTI)

Stock Price: $35.01 USD 0.63 (1.83%)
Updated Jan 15, 2021 4:00 PM EST - Market closed
Market Cap 1.22B
Revenue (ttm) n/a
Net Income (ttm) n/a
Shares Out 34.77M
EPS (ttm) n/a
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a
Trading Day January 15
Last Price $35.01
Previous Close $34.38
Change ($) 0.63
Change (%) 1.83%
Day's Open 33.93
Day's Range 32.99 - 35.50
Day's Volume 66,259
52-Week Range 17.98 - 35.50

News

There are no news available yet.

About AMTI

Applied Molecular Transport, a clinical-stage biopharmaceutical company, engages in the development of a pipeline of oral biologic product candidates to treat autoimmune, inflammatory, metabolic, and other diseases. Its lead product candidate is AMT-101, an oral gastrointestinal (GI) selective interleukin 10 that has completed a Phase 1b clinical trial in patients with ulcerative colitis (UC). The company, through its technology platform designs and develops various oral biologic therapeutic modalities, such as peptides, proteins, antibodies, a... [Read more...]

Industry
Biotechnology
IPO Date
Jun 5, 2020
CEO
Dr. Tahir Mahmood
Employees
64
Stock Exchange
NASDAQ
Ticker Symbol
AMTI
Full Company Profile

Financial Performance

Financial Statements

Analyst Forecasts

According to 3 analysts, the average rating for AMTI stock is "Strong Buy." The 12-month stock price forecast is 34.67, which is a decrease of -0.97% from the latest price.

Price Target
$34.67
(-0.97% downside)
Analyst Consensus: Strong Buy